kriti singh

kriti singh

Followers 0
Following 0
IN
The medical ceramics market is expected to reach USD 18.45 Billion by 2022 from an estimated USD 13.38 Billion in 2017, at a CAGR of 6.6% during the forecast period.The medical ceramics market is driven by the growing demand for plastic surgeries, increase in cancer incidence, growing prevalence of cardiovascular diseases, and growing number of conferences and symposiums.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237425129 By type of material, the bioinert ceramics segment is expected to account for the largest share of the market in 2017 On the basis of type of material, the medical ceramics market is broadly segmented into bioinert ceramics, bioactive ceramics, bioresorbable ceramics, and piezoceramics.This can be attributed to the advantages of zirconia over other ceramic materials, rising demand for attractive dental restorations, the launch of new and advanced products, and growing research activities for the development of novel products.By application, the dental applications segment is expected to command the largest share of the market in 2017 On the basis of application, the market is broadly segmented into dental applications, orthopedic applications, cardiovascular applications, surgical instruments, diagnostic instruments, plastic surgery, and other applications (cancer, dialysis, drug delivery systems, and gene therapy).The large share of this segment can be attributed to the increasing number of cosmetic dental procedures and dental implant procedures across various regions and the rising cases of periodontal disorders.
AT
The demand for sepsis diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the rising number of sepsis incidences, and growing government initiatives for creating sepsis awareness.What the Market Looks Like?Predicted to grow at a CAGR of 8.5% during the forecast period, the global sepsis diagnostics market is estimated to reach USD 700 million by the end of 2025.North America is estimated to account for the largest share of the market in 2019.North America is a well-established market for medical devices.The sepsis diagnostics market, by technology, the market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers.In 2019, the blood culture segment accounted for the largest share of the market.This share can be attributed to the low cost of microbiology techniques and the extensive use of blood culture methods for the diagnosis of sepsis.Download PDF Brochure @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155What Drives the Market?The growth of the global market for Sepsis Diagnostics is primarily influenced by the following factors:High incidence of sepsisRising incidence of hospital-acquired infectionsGrowing funding for sepsis-related researchMoreover, these factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155 
2
UK
Market Overview Factors such as increasing aging population and rise in the disabled population are propelling the growth of this market.However, high costs of bathroom & toilet assist devices may restrict the growth of this market.A number of factors such as healthy growth of commodes and shower chairs & stools market, high growth potential of emerging economies, and acquisitions have opened an array of opportunities for the market to grow in the coming years.The global bathroom & toilet assist devices market is expected to reach USD 4.68 Billion by 2020, at a CAGR of 5.7% from 2015 to 2020.Market Segmentations The global bathroom & toilet assist devices market is segmented into product type and geography.Product Type Based on product type this market is segmented into shower chairs & stools, bath lifts, toilet seat raisers, toilet aids, commodes, handgrips & grab bars, and bath aids.
3
IN
Factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies are expected to drive the growth of this protein engineering market in the coming years.However, factors such as the high cost of instruments and laboratory documentation systems are expected to restrain the growth of this market during the forecast period.The protein engineering market is estimated to grow from USD 2.2 billion in 2019 to USD 3.9 billion by 2024, at a CAGR of 12.4% during the forecast period.Factors such as the presence of well-established CROs, rising R expenditure, and the availability of the latest techniques and instruments for drug discovery research are responsible for the large share of the market.The global protein engineering market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.In 2019, North America accounted for the largest share of this market majorly due to the advancements in genomics and proteomics research and government initiatives and funding for protein-based drug research.
2
IN
According to the new market research report "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.The live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% during the forecast period (2018–2023).The growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research are the major factors driving the growth of the global live cell imaging market.However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483 The instruments segment accounted for the largest share of the market in 2018 On the basis of product and service, the global live cell imaging market is segmented into instruments, consumables, software, and services.Factors such as the launch of new and advanced instruments, increasing incidence of diseases, and rising government initiatives and awareness programs for promoting cell-based research are the major factors driving the demand for live cell imaging instruments.
1
US
According to the latest research report “Peptide and Anticoagulant Drugs Market by Type (Hormonal (Insulin, Teriparatide, Calcitonin), Antibiotic (Colistin, Cycloserine), Low molecular weight heparin (Enoxaparin Sodium, Heparin Sodium), Application (Diabetes, Cancer) - India Forecast to 2022” published by MarketsandMarkets.The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.Factors such as increasing prevalence of chronic diseases, rising aging population, and increasing healthcare expenditure are contributing to the growth of this market.The Indian peptide drugs market is segmented by type and application.By type, the Indian peptide drugs market is segmented into hormonal, antifungal, antibiotic, ACE inhibitor and others.Hormonal segment dominated the Indian peptide drugs market in 2016.The growing incidence of diabetes, cancer diseases in India are the key factors driving the growth of this segment.On the basis of application, the Indian peptide drugs market segmented into diabetes, cancer, cardiovascular disease (CVD), gynecological application, infectious diseases, osteoporosis, and other applications (acromegaly, multiple sclerosis, and hepatitis).Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77044734 Diabetes segment accounts for the largest segment and is also the fastest growing application segment in the market.
IN
Report Overview [132 Pages Report] The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3%.The growth of this market is majorly driven by the growing preference for cell-based assays, increasing research funding, and the growth in the number of drug discovery activities.However, the high cost of instruments and restrictions on reagent use are the major factors restraining the growth of this market.This growth can be attributed to the increasing number of drug discovery activities, especially in emerging markets.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269 Increasing use of cell-based assays in drug discovery to drive market growth during the forecast period Based on application, the market is segmented into drug discovery, basic research and other applications such as quality check among others.This growth can be attributed to the increase in R investment by biopharmaceutical companies.
2
IN
Bed & Baby Monitoring System Market Overview[86 Pages Report] The bed monitoring system market is expected to grow from USD 1.3 billion in 2019 to USD 1.9 billion by 2024, at a CAGR of 7.9% during the forecast period.The report covered sensor pads or smart mattresses embedded with the sensors for bedsore monitoring, baby monitoring, elderly monitoring, and sleep monitoring.The growth of this market is driven primarily by factors such as growing investments in healthcare infrastructural development, increasing elderly population, rising adoption of unobtrusive monitoring solutions, increasing focus on reducing the treatment cost of pressure ulcer & fall injuries and increasing online availability & purchase of products.However, lack of awareness and acceptance of the products in developing countries is expected to restrain the growth of this market during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62445948Baby monitoring segment accounted for the largest share of the bed monitoring system & baby monitoring system market in 2018Based on type, the bed monitoring system & baby monitoring system market is divided into baby monitoring, elderly monitoring, bedsore monitoring, and sleep monitoring.The baby monitoring segment accounted for the largest share of the bed monitoring system & baby monitoring system market in 2018.The large share of this segment is attributed the availability of new products, increasing awareness among parents, and growing adoption of baby monitors in homecare settings.The homecare settings end-user segment is expected to grow in the near futureBy end-user type, the bed monitoring system & baby monitoring system market is segmented into homecare settings, hospitals, nursing home, and assisted living facilities.The homecare settings segment dominated the bed monitoring system & baby monitoring system market in 2018.This segment is expected to grow at the highest rate during the forecast period, mainly due to the increasing use of sleep monitoring devices and baby monitors in homecare settings and the growing adoption for unobtrusive monitors in home care for the elderly population.Report Geographical Region                                                            In 2018, North America held the largest share of the bed monitoring system & baby monitoring system market.However, Asia Pacific is estimated to grow at the highest CAGR during the forecast period.The rapid growth in the healthcare industry, widespread policy reforms, the rapidly growing middle-class population with increasing purchasing power, and significant investments in infrastructural development are supporting the growth of the Asia Pacific bed monitoring system & baby monitoring system market.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=62445948Report Key Players and Market SharesThe prominent players in this market include  Wellsense (US), Xsensor Technology Corporation (Canada), Early Sense (US), Tekscan (US), Sensing Tex (Spain), Infant optics (US), Lenovo Group (Hong Kong), Philips (Netherlands), Hisense (Israel), Vtech Communications (Hong Kong), Nanit (US), iBaby Labs (US), Emfit (Finland), Smart Caregiver Corporation (US), Eight Sleep (US), Withings (France), Beddit (Finland), Sleep Number Corporation (US).Key questions addressed by the report:Who are the major market players in the bed monitoring system & baby monitoring system market?What are the regional growth trends and the largest revenue-generating regions?What are the major drivers and challenges in the bed monitoring system & baby monitoring system market?What are the major type segments in the bed monitoring system & baby monitoring system market?What are the major end-user segments in the bed monitoring system & baby monitoring system market?Inquiry about Bed Monitoring System Market before buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=62445948 
IN
Need for better asset management in hospitals, acceptance of asset management solutions in the pharmaceutical industry, and decline in prices of RFID Tags are driving the growth of the healthcare asset management market.The global healthcare asset management market is projected to reach USD 35.19 billion by 2023 from USD 8.98 billion from 2018, at a CAGR of 31.4%.Need for better asset management in hospitals Growing pressure to better manage their existing workforce has compelled healthcare organizations across the globe to adopt effective asset management solutions and technologies.For example, it was reported that ~USD 6 million worth of state-owned hospital equipment was found to be missing in Louisiana State University (LSU) hospitals; newly purchased equipment from the hospital were also not properly tracked.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1195 Acceptance of asset management solutions in the pharmaceutical industry The use of radiofrequency identification (RFID) in the pharmaceutical industry has grown in recent years.The technology has emerged to become a systematic part of supply chain management in international pharmaceutical production and distribution.
IN
Tissue Diagnostics industry is experiencing significant growth due to the rising incidence of cancer, developing infrastructure for cancer diagnosis, recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure.What the Tissue Diagnostics Market Looks Like?Predicted to grow at a CAGR of 14.8 % during the forecast period, the global tissue diagnostics market is estimated to reach USD 2.31 billion by 2022.This report segments the tissue diagnostics product market into product, technology, diseases, end user, and region.Based on the product, the tissue diagnostics market is segmented into instruments and consumables.The increasing number of reagent rental agreement is also one of the major factors to drive the growth of the consumables market globally Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949 Based on the technology, the tissue diagnostic market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining.
IN
According to the latest research report "Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023", published by MarketsandMarkets.The Slide Stainer Market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%.The major factors driving the growth of this market include the increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure.By product, the reagents segment accounted for the largest share of the slide stainers market in 2017On the basis of product, the reagents segment accounted for the largest share of the global slide stainers market in 2017.The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.By technology, the hematoxylin & eosin (H) segment held the largest share in 2017Based on technology, the slide stainers market is segmented into hematoxylin and eosin (H), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains.In 2017, the H segment accounted for the largest share of the slide stainers market.The large share of this segment can be attributed to the fact that H staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412By end user, the hospitals and diagnostic centers segment held the largest share of the slide stainers market in 2017On the basis of end user, the slide stainers market is segmented into hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies and other end users (contract research organizations and forensics, food, & environmental laboratories).The hospitals and diagnostic centers segment accounted for the largest share in 2017.Factors such as the growing prevalence of diseases and huge patient inflow in hospitals and diagnostic centers are driving the growth of this end-user segment.North America dominated the market in 2017North America accounted for the largest share of the slide stainers market in 2017, followed by Europe and Asia Pacific.
IN
Factors such as the rapid rise in livestock population, increasing awareness about animal health, growing demand for animal-derived food products, and rising frequency of animal disease outbreaks are the major factors driving the growth of the Asia-Pacific Animal Health market.What the Market Looks Like?Predicted to grow at a CAGR of 5.7% during the forecast period, the global animal health market is estimated to reach USD 20.25 billion by the end of 2021.Geographically, the Asia-Pacific Animal Health market is segmented into China, Japan, India, and the Rest of APAC.In 2015, China commanded a major share of the market and is expected to witness the highest growth rate during the forecast period.Based on product, the market is segmented into growth promoters, feed additives, vaccines, parasiticides, antimicrobials and antibiotics, and other pharmaceuticals.Growth promoters accounted for the largest share of the market in 2015 owing to its wide utilization by livestock producers and pet owners.Based on the type of animal, the market is segmented into food-producing animals and companion animals.The food-producing animals segment accounted for the largest share of the market, while companion animals are expected to register the highest growth during the forecast period.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485What Drives the Market?The growth of the global market for animal health is primarily influenced by the following factors:Rising Demand for Animal-Derived Food ProductsIncreasing Livestock Population and Growing Awareness About Animal HealthGrowing Frequency of Animal Disease OutbreaksHowever, restrictions on the use of parasiticides in food-producing animals, rising storage cost of animal vaccines, and the shift towards vegetarian diets are restraining the growth of this market to a certain extent.Geographical Region of Animal Health MarketGeographically, the Asia-Pacific Animal Health market is segmented into China, Japan, India, and the Rest of APAC.
2
IN
Factors such as the increasing funding for life sciences research, high global prevalence of cancer, and growth in stem cell and neurobiology research are expected to drive the growth of cell surface markers market in the coming years. The cell surface markers market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, at a CAGR of 8.1% during the forecast period. On the basis of antibodies by source, the global cell surface markers industry is segmented into mice, rats, and other sources. However, the market in Asia is estimated to grow at the highest CAGR during the forecast period. Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216278622 Key Market Players The cell surface markers market is highly fragmented in nature, with several big as well as emerging players. The strong position of the company in this market can be attributed to its robust product portfolio.
1
IN
Rising geriatric population and increasing conferences and symposiums help create awareness on market products and the latest technologies in hearing aids are the major factors supporting the growth of hearing aids market.The hearing aids market is expected to reach USD 9.78 Billion by 2022 from USD 6.97 Billion in 2017, at a CAGR of 7.0%.The high growth in this market is attributed to the high prevalence of hearing loss, availability of technologically advanced hearing aids, growth in the aging population, and increasing initiatives by companies to expand in these emerging economies.While the hearing aids market presents significant growth opportunities, market growth may be hindered due to the high cost of hearing aids and the low penetration of these devices.Based on product, the hearing aids market is segmented into hearing aid devices and hearing implants.In 2017, the hearing aid devices segment is expected to account for the largest share of the hearing aids market.
3
IN
Real-world data (RWD) is defined as data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings.The global real-world evidence market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%.The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs).The rising focus on end-to-end RWE services and growth opportunities in emerging markets are expected to provide further growth opportunities for players operating in the real world evidence market.However, the reluctance to rely on real-world studies and the lack of universally accepted methodological standards for data collection some of the factors limiting the growth of this market during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76173991 Real World Evidence Market, By Component IntroductionData SetsClinical Setting DataClaims DataPharmacy DataPatient Powered DataServicesReal World Evidence Market, By Therapeutic Area OncologyCardiovascular DiseaseNeurologyImmunologyOthers Therapeutic AreasReal World Evidence Market, By End User Pharmaceutical and Medical Device CompaniesHealthcare PayersHealthcare ProvidersOther End UsersReal world evidence Market, By Region North AmericaUSCanadaEuropeGermanyUKFranceItalySpainRest Of EuropeAsia Pacific (APAC)ChinaJapanRest of APACRest of the WorldKey Players The prominent players in the global real world evidence solutions market are IQVIA (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), International Business Machines Corporation (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).
3
IN
In current scenario of the dental industry, there is demand for fast production of highly customized dental products.Since, the 3D printing is a well-established option for faster production of the customized parts, easy to use, highly accurate, and cost effective 3D printing solution are being increasingly preferred over the milling-based methods.The technology advancements in hardware, materials, and the software are driving the adoption of dental 3D printing & scanning equipment.What the Market Looks Like?Predicted to grow at a CAGR of 23.2% during the forecast period, the global dental 3d printing market is estimated to reach USD 5.06 billion by the end of 2023.North America accounted for the largest share of the dental 3D printing market in 2017, followed by Europe and Asia Pacific.Asia Pacific region is expected to grow at a higher CAGR during the forecast period.
1
IN
The major factors that are expected to be driving the veterinary software Industry are rising companion animal ownership and demand for pet insurance with growing animal health expenditure.However, lack of government incentives for the adoption of veterinary software, reluctance of veterinarians towards adopting new technologies, and lack of awareness about veterinary software in the developing countries are restricting the growth of this market.What the Veterinary Software Industry Looks Like?MarketsandMarkets forecasts the veterinary software market to grow from USD 442 million in 2017 to USD 594 million by 2022, at a CAGR of 6.1% during the forecast period.Rising Companion Animal OwnershipOver the years, the number of pet owners has increased significantly across the globe, and this trend is expected to continue in the coming years.According to the American Pet Products Association’s 2017– 2018 National Pet Owners Survey, 68% of households (84.6 million) in the US owned a pet.In the UK, as of 2017, 44% of households own pets (Source: Pet Food Manufacturers Association).Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186264514Restraint: Lack of Government IncentivesThe veterinary software Industry has minimal support from governments across the globe.In the US, the adoption rate of veterinary software is very low as compared to healthcare IT (HCIT) tools such as human EHR.The slow adoption rate of veterinary software will make it difficult for small vendors to break even in the market.
IN
The rising need to curtail healthcare costs, increasing incidences of medical errors & hospital-acquired infections, and growing government initiatives to improve patient safety and patient outcomes are key drivers of patient safety and risk management solutions market.What the Patient Safety and Risk Management Market Looks Like?The patient safety and risk management solutions market is estimated to be worth USD 2.2 billion by 2024 from a value of USD 1.3 billion in 2019, growing at a CAGR of 11.2% during the forecast period.Much of this growth is driven by the increasing patient population, rapid return on investment (ROI), and rising government initiatives to improve the patient safety & patient outcomes in healthcare.Based on type, the market for governance, risk, & compliance (GRC) solutions is expected to grow at the highest rate during the forecast period.The growth of the global market for Patient Safety Management Solutions is primarily influenced by the following factors:Increasing Need to Curtail Rising Healthcare CostsGrowing Focus on Improving Patient OutcomesGovernment Initiatives to Improve Patient Safety and Patient OutcomesOn the other hand, the dearth of in-house IT expertise and the reluctance of healthcare providers to adopt new methods of patient safety and risk management are expected to restrain the growth of the market to a certain extent during the forecast period.
1
IN
[144 Pages Report] The global Healthcare Fraud Analytics Market is projected to USD 4.6 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 29.8%.The growth of this market is mainly due to a rise in the number of fraudulent activities in healthcare, combined with the increasing number of patients seeking medical insurance and rising pharmacy claim-related frauds.Emerging markets like APAC and Latin America provide significant growth opportunities in this market.The high share of this market is attributed to the large number of people having health insurance, growing healthcare fraud, favorable government anti-fraud initiatives, the pressure to reduce healthcare costs, technological advancements, and greater product and service availability in this region.Moreover, a majority of leading players in the healthcare fraud detection market have their headquarters.Fraud analytics solutions vary from vendor to vendor.Some vendors offer rule-based models while others offer AI-based technologies, but broadly, these solutions are classified based on the type of analytics used—descriptive analytics, predictive analytics, and prescriptive analytics.
IN
[144 Pages Report] The global Healthcare Fraud Analytics Market is projected to USD 4.6 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 29.8%.The growth of this market is mainly due to a rise in the number of fraudulent activities in healthcare, combined with the increasing number of patients seeking medical insurance and rising pharmacy claim-related frauds.Emerging markets like APAC and Latin America provide significant growth opportunities in this market.The high share of this market is attributed to the large number of people having health insurance, growing healthcare fraud, favorable government anti-fraud initiatives, the pressure to reduce healthcare costs, technological advancements, and greater product and service availability in this region.Fraud analytics solutions vary from vendor to vendor.Some vendors offer rule-based models while others offer AI-based technologies, but broadly, these solutions are classified based on the type of analytics used—descriptive analytics, predictive analytics, and prescriptive analytics.
IN
Market Overview [117 Pages Report] The global bone densitometers market is projected to reach USD 311 million by 2024 from USD 247 million in 2019, at a CAGR of 4.7%. The growth in the bone densitometer market is majorly driven by the increasing prevalence of osteoporosis and the rising geriatric population. The DXA scanners segment accounted for the largest share of the market in 2018. Moreover, results obtained from DXA scanners can be interpreted using WHO scores for greater accuracy, which accounts for their high use. Application On the basis of application, the market has been segmented into osteoporosis & osteopenia diagnosis, body composition measurement, rheumatoid arthritis diagnosis, cystic fibrosis diagnosis, and chronic kidney disease diagnosis. This can be attributed to the growing geriatric population and the subsequent increase in the prevalence of osteoporosis, the increasing risk of osteoporosis in menopausal women, and the growing global incidence of fragility fractures.
2
IN
MarketsandMarkets™ published a report titled, “Cleanroom Technologies Market by Product (HVAC, HEPA filters, air shower, apparel, gloves, vacuum systems, disinfectants), Construction (Drywall, Hardwall, Softwall), End User (Pharmaceutical, Biotechnology, Hospitals) - Global Forecast to 2024”.Based on their findings, the cleanroom technologies Market size is expected to be valued at USD 7.9 billion by 2024 from USD 5.7 billion in 2019, growing at a CAGR of 6.6% during 2019-2024.The major factors driving the growth of this market are the stringent regulatory framework, growth of the biologics sector, rising demand for sterilized pharmaceutical formulations, growing demand for medical devices, and technological advancements in cleanroom technology.By product, the consumables segment is expected to account for the largest share of the cleanroom technologies marketThe consumables segment is estimated to account for the largest market share in 2018.The large share of this segment can be attributed to the high and growing number of pharmaceutical, biotech, and medical device companies facilitating the use of disposable protective clothing.Also, the large number of R activities in the healthcare industry is resulting in a stable demand for cleanroom consumables among end-users.This segment includes safety consumables and cleaning consumables.Browse in-depth TOC on “Cleanroom Technology Market“212 – Tables30 – Figures 214 – PagesDownload a PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263122482Asia Pacific is estimated to be the fastest-growing market for cleanroom technologies during the forecast periodThe APAC market is projected to register the highest growth during the forecast period.
1
IN
The major driving factors for process and preparative chromatography market include increasing demand for insulin and other biopharmaceutical products, high demand for omega-3 fatty acids, and rising awareness about advancements in process and preparative chromatography.Emerging economies such as India, China, and Brazil provide opportunity for the players operating in the process and preparative market.However, high cost of instrument and availability alternative techniques for purification and separation of pharmaceutical products are the major restraining factors for this market.The process and preparative chromatography market size is expected to reach USD 8.60 billion by 2023 from the estimated USD 6.27 billion in 2018, at a CAGR of 6.5%.The process chromatography segment is estimated to command the larger market share in 2018.This is mainly due to increasing production of vaccines and monoclonal antibodies in biotechnology and pharmaceutical industries.
1
IN
CRISPR Technology Market by Product (Enzymes, Kits, gRNA, Libraries, Design Tools), Service (gRNA Design, Cell Line Engineering), Application (Biomedical, Agricultural), End User (Pharma & Biopharma Companies, Academics, CROs) - Global Forecast to 2023″ published by MarketsandMarkets™, the CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period.The major factors driving the CRISPR technology market include the rising funding from government and private organizations and the high adoption of CRISPR technology.The CRISPR technology market, by product and service, is estimated to be dominated by the products segment in 2018.This is attributed to the fact that the CRISPR technology is being adopted quickly by academics and researchers, pharma and biotech companies.The enzymes segment is expected to account for the largest share of the products market, being one of the key ingredients in the CRISPR process.Companies like Merck KGaA and Thermo Fisher Scientific are providing hands-on training to researchers, which will increase the demand for CRISPR products in the future.Browse and in-depth TOC on “CRISPR Technology Market”132 – Tables24 – Figures163 – PagesDownload a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204The biomedical applications segment is projected to be the fastest-growing segment of the market, by application, during the forecast period.Developments in gene therapy, drug discovery, and diagnostics, due to the application of CRISPR, are driving the growth of this biomedical segment.Many companies have also invested in drug discovery and gene therapy companies that are using CRISPR technology.North America is estimated to account for the largest share of the market in 2018.
2
IN
 The rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players are large share of cell expansion market The cell expansion market is projected to reach USD 26.0 billion by 2024 from USD 12.7 billion in 2019, at a CAGR of 15.4% during the forecast period.Growth in this market is mainly driven by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.The cell expansion market is segmented into consumables and instruments.Consumables are segmented into reagents, media, sera, and disposables.The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems.In 2018, consumables accounted for the largest share of the cell expansion products market owing to the constant requirement for new reagents among end users and rising investments for R on cell-based therapies.Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=194978883 Cell Expansion Market, by ProductConsumablesInstrumentsCell Expansion Market, by Cell TypeHuman CellsAnimal CellsCell Expansion Market, by ApplicationRegenerative Medicine and Stem Cell ResearchCancer and Cell-based ResearchOther Applications (clinical studies, toxicology studies)Cell Expansion Market, by End UserResearch InstitutesBiotechnology and Biopharmaceutical CompaniesCell BanksOther End Users (Hospitals and diagnostic laboratories)Cell Expansion Market, by RegionNorth AmericaUSCanadaEuropeGermanyUKFranceItalySpainRest of EuropeAsia PacificChinaJapanIndiaSingaporeSouth KoreaRest of Asia PacificRest of the WorldLatin AmericaThe Middle East and AfricaKey PlayersSome of the prominent players in the global cell expansion industry market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), Miltenyi Biotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US).Recent DevelopmentsIn 2016, Thermo Fisher Scientific acquired Affymetrix Inc. (US) for USD 1.3 billion.
IN
 MarketsandMarkets forecasts the Healthcare Supply Chain Management Market to grow from USD 3.3 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 7.9% during the forecast period.The key factors driving the growth of this market include the adoption of GS1 system of standard in the healthcare industry globally, the emergence of cloud-based solutions, reduction in operational costs by improving the efficacy and increase in overall profitability.However, the high cost of implementation of supply chain management software is expected to restrict market growth to a certain extent.Cloud-based solutions help healthcare organizations share and integrate information from disparate locations; these solutions also offer minimum costs of installation and maintenance.In this regional market, the US is expected to offer potential growth opportunities to market players in the coming years.Key Market Players SAP SE (Germany), Oracle Corporation (US), Infor (US), McKesson Corporation (US), TECSYS (US), Global Healthcare Exchange (US), Cardinal Health (US), Determine (US), Epicor (US), LLamasoft (US), Manhattan Associates (US), Blue Yonder Group, Inc. (JDA Software) (US), Cerner (US), Jump Technologies (US), LogiTag Systems (US), Harris Affinity (US), Premier (US), Accurate Info Soft (US), Hybrent (US), and Arvato Systems (Germany).
1
IN
 There has been a tremendous increase in the use of urine analysis and has become a part of any general health check up in the past decade.Increasing research activities in the field of urinalysis and growing awareness of personalized medicine have also resulted in the establishment point of care systems.Automated devices have also been installed in the large hospitals and laboratories.The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024 Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294 Urinalysis Market, By Product ConsumablesPregnancy & Fertility KitsDipsticksDisposablesReagentsInstrumentsAutomated Urine AnalyzersSediment Urine AnalyzersSemi-Automated Urine AnalyzersPoint-Of-Care Urine AnalyzersUrinalysis Market, By Test Type Pregnancy & Fertility TestsBiochemical UrinalysisLaboratory TestsPoint-Of-Care TestsSediment UrinalysisUrinalysis Market, By Application Disease ScreeningUrinary Tract InfectionsKidney DiseasesDiabetesLiver DiseasesPregnancy & FertilityUrinalysis Market, By End Users Hospitals & ClinicsDiagnostic LaboratoriesClinicsResearch Laboratories & InstitutesUrinalysis Market, By Region North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalySpainRoEAsia-PacificJapanChinaIndiaRoAPACRest of the World (RoW)Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294 This report covers the Urinalysis Systems Market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
IN
They accurately detect abnormalities which are not visible during routine dental examination.The global market for dental digital X-ray is expected to reach $3,290.6 million by 2020 from $2,154.0 million in 2015, at a CAGR of 8.8% during the forecast period.Apart from dental caries and oral cancer, the growth in the decayed, missing, and filled teeth (DMFT) index is also expected to fuel the demand for endodontic treatments such as root canals and periodontal treatments such as scaling and root planning.Download a PDF [email protected] https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102002511 Technological advancements for efficient and effective diagnosis are a major driver for diagnostics applications segment Diagnostic Diagnostic applications extensively involve the use of dental CBCT (cone-beam computed tomography), intraoral sensors, PSP (photostimulable phosphor) systems, and panoramic and cephalometric X-rays.These systems help diagnose various dental disorders such as bone loss or infections in the bone, periodontal (gum disease), abscesses or cysts, developmental abnormalities, cancerous and non-cancerous tumors, poor tooth and root positions, and other conditions inside a tooth or below the gum line.Due to technological advancements in dental imaging systems and digitization in dentistry, restorative dentistry has undergone significant changes over the years.
2
IN
The increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries are driving the growth of hemostats market.In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market.In this report, the global hemostats market is segmented based on product, application, formulation, and region.Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats.Target Audience Manufacturers and vendors of hemostats productsDistributors of hemostats productsVenture capitalistsVarious research and consulting firmsHospitals and clinicsAmbulatory surgical centersMedical device companiesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9571619 Application Based on applications, the hemostats market is segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery.The growing geriatric population, increasing incidence of sports injuries, and the growing prevalence of lifestyle disorders (such as arthritis, osteoporosis, and obesity) are some of the major factors responsible for the growth in the number of orthopedic surgeries performed globally.
IN
Increasing prevalence of chronic diseases such as diabetes, cancer, and osteoporosis and favorable government policies for the pharmaceutical sector are expected to drive the growth of Indian peptide drugs market.The growing incidence of coagulation disorders and government support for pharmaceutical companies are expected to drive the growth of Indian anticoagulant drugs market.How much is the Indian peptide drugs Market anticoagulant drugs market worth?The Indian peptide drugs market is expected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.The Indian anticoagulant drugs market is expected to reach USD 170.2 Million by 2022 from USD 127.8 Million in 2016, at a CAGR of 4.9%.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77044734By type, hormonal segment is expected to dominate the market in 2016On the basis of type segmentation, The Indian peptide drugs market is classified into hormonal, antifungal, antibiotic, ACE inhibitor and others.The hormonal segment is expected to dominate the Indian peptide drugs market in 2016.Growing incidence and prevalence rate of diabetes in India and rising ageing population are the major driving factors for this segment.By application, the diabetes segment is expected to dominate the market in 2016Based on application, the indian peptide drugs market is segmented into diabetes, infectious disease, cancer, cardiology, osteoporosis, gynecological application, and other applications.In 2016, the diabetes segment is expected to account for the largest share of the Indian peptide drugs market, by application.The growth in the segment can be primarily attributed to increasing incidence and prevalence of diabetes cases in the country.By type, Enoxaparin sodiumsegment is expected to dominate the market in 2016On the basis of Low molecular weight heparin type, the Indian anticoagulant drugs market is classified into enoxaparin sodium, heparin sodium, fondaparinux, and dalteparin sodium.In 2016, the enoxaparin sodium segment is expected to account for the largest share of the Indian anticoagulant drugs market, by type.
3
More

Top